scholarly journals Evaluation of the DSM-5 severity indicator for binge eating disorder in a clinical sample

2015 ◽  
Vol 71 ◽  
pp. 110-114 ◽  
Author(s):  
Carlos M. Grilo ◽  
Valentina Ivezaj ◽  
Marney A. White
2017 ◽  
Vol 11 (3) ◽  
pp. 237-245 ◽  
Author(s):  
O. Ziegler ◽  
J. Mathieu ◽  
P. Böhme ◽  
P. Witkowski

2017 ◽  
Author(s):  
Patricia Westmoreland ◽  
Phillip S Mehler

Feeding and eating disorders are defined by persistent disturbance of eating (or behaviors related to eating) with subsequent changes in consumption or absorption of nutrition that are detrimental to physical health and social functioning. The following eating disorders are described in the DSM-5: anorexia nervosa, bulimia nervosa, binge eating disorder, pica, rumination disorder, avoidant/restrictive food intake disorder (ARFID), other specified feeding or eating disorder (OSFED), and unspecified feeding or eating disorder (USFED). ARFID, OSFED, USFED, rumination disorder, and binge eating disorder are new additions to the manual and are first described in the DSM-5. The DSM-5 also provides severity specifiers—mild, moderate, severe, and extreme—for the diagnoses of bulimia nervosa and anorexia nervosa. This review describes the eating disorders enumerated in the DSM-5 and provides information regarding their genesis and course. This review contains 8 tables and 79 references Key words: avoidant/restrictive eating disorder, binge eating disorder, DSM-5, eating disorder, other specified feeding or eating disorder, pharmacotherapy, pica rumination, psychotherapy, unspecified feeding or eating disorder


2017 ◽  
Vol 50 (9) ◽  
pp. 1109-1113 ◽  
Author(s):  
Kathryn E. Smith ◽  
Jo M. Ellison ◽  
Ross D. Crosby ◽  
Scott G. Engel ◽  
James E. Mitchell ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Jennifer J. Thomas ◽  
Katherine A. Koh ◽  
Kamryn T. Eddy ◽  
Andrea S. Hartmann ◽  
Helen B. Murray ◽  
...  

Background.DSM-5revisions have been criticized in the popular press for overpathologizing normative eating patterns—particularly among individuals with obesity. To evaluate the evidence for this and otherDSM-5critiques, we compared the point prevalence and interrater reliability ofDSM-IVversusDSM-5eating disorders (EDs) among adults seeking weight-loss treatment.Method.Clinicians (n=2) assignedDSM-IVandDSM-5ED diagnoses to 100 participants via routine clinical interview. Research assessors (n=3) independently conferred ED diagnoses via Structured Clinical Interview forDSM-IVand aDSM-5checklist.Results. Research assessors diagnosed a similar proportion of participants with EDs underDSM-IV(29%) versusDSM-5(32%).DSM-5research diagnoses included binge eating disorder (9%), bulimia nervosa (2%), subthreshold binge eating disorder (5%), subthreshold bulimia nervosa (2%), purging disorder (1%), night eating syndrome (6%), and other (7%). Interrater reliability between clinicians and research assessors was “substantial” for bothDSM-IV(κ= 0.64, 84% agreement) andDSM-5(κ= 0.63, 83% agreement).Conclusion.DSM-5ED criteria can be reliably applied in an obesity treatment setting and appear to yield an overall ED point prevalence comparable toDSM-IV.


2015 ◽  
Vol 16 ◽  
pp. 1-4 ◽  
Author(s):  
Piergiuseppe Vinai ◽  
Annalisa Da Ros ◽  
Maurizio Speciale ◽  
Nicola Gentile ◽  
Anna Tagliabue ◽  
...  

2017 ◽  
Author(s):  
Patricia Westmoreland ◽  
Phillip S Mehler

Feeding and eating disorders are defined by persistent disturbance of eating (or behaviors related to eating) with subsequent changes in consumption or absorption of nutrition that are detrimental to physical health and social functioning. The following eating disorders are described in the DSM-5: anorexia nervosa, bulimia nervosa, binge eating disorder, pica, rumination disorder, avoidant/restrictive food intake disorder (ARFID), other specified feeding or eating disorder (OSFED), and unspecified feeding or eating disorder (USFED). ARFID, OSFED, USFED, rumination disorder, and binge eating disorder are new additions to the manual and are first described in the DSM-5. The DSM-5 also provides severity specifiers—mild, moderate, severe, and extreme—for the diagnoses of bulimia nervosa and anorexia nervosa. This review describes the eating disorders enumerated in the DSM-5 and provides information regarding their genesis and course. This review contains 8 tables and 79 references Key words: avoidant/restrictive eating disorder, binge eating disorder, DSM-5, eating disorder, other specified feeding or eating disorder, pharmacotherapy, pica rumination, psychotherapy, unspecified feeding or eating disorder


2016 ◽  
Vol 22 ◽  
pp. 145-148 ◽  
Author(s):  
Linda Mustelin ◽  
Ulla Kärkkäinen ◽  
Jaakko Kaprio ◽  
Anna Keski-Rahkonen

CNS Spectrums ◽  
2019 ◽  
Vol 24 (S1) ◽  
pp. 4-13 ◽  
Author(s):  
Leslie Citrome

Binge eating disorder (BED) is the most common type of eating disorder. According to the most recent data available, the estimated lifetime prevalence of BED among US adults in the general population is 0.85% (men 0.42% and women 1.25%). Among psychiatric treatment populations, prevalence is several-fold higher. Although many people with BED are obese (BMI ≥ 30 kg/m2), roughly half are not. In the DSM-5, BED is defined by recurrent episodes of binge eating (eating in a discrete period of time, an amount of food larger than most people would eat in a similar amount of time under similar circumstancesanda sense of lack of control over eating during the episode), occurring on average at least once a week for 3 months, and associated with marked distress. BED often goes unrecognized and thus untreated; in one study, 344 of 22,387 (1.5%) survey respondents met DSM-5 criteria for BED, but only 11 out of the 344 had ever been diagnosed with BED by a health-care provider. Psychiatric comorbidities are very common, with most adults with BED also experiencing anxiety disorders, mood disorders, impulse control disorders, or substance use disorders, suggesting that clinicians have patients in their practice with unrecognized BED. Multiple neurobiological explanations have been suggested for BED, including dysregulation in reward center and impulse control circuitry. Additionally, there is interplay between genetic influences and environmental stressors. Psychological treatments such as cognitive behavioral interventions have been recommended as first line and are supported by meta-analytic reviews; however, access to such treatments may be limited because of local availability and/or cost, and these treatments generally lead to little to no weight loss, although successfully eliminating binge eating can protect against future weight gain. Routine medication treatments for anxiety and depression do not necessarily ameliorate the symptoms of BED, but there are approved and emerging medication options, lisdexamfetamine and dasotraline, respectively, that specifically address the core drivers behind binge eating, namely obsessive thoughts and compulsive behaviors regarding food, resulting in marked decreases in binge eating behaviors as well as weight loss.


Sign in / Sign up

Export Citation Format

Share Document